United States Pharmaceuticals

Ocera Therapeutics Inc (OCRX)

Track

Ticker: OCRX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 28 Mar 2017
Value US$1,787,461.40 | Price 26.70 | Shares 59,315 (+18.0%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-03-28 2017-03-28 B Purchase Byrnes Michael

CFO and Treasurer
59,315 +18.0%
26.70
US$1,787,461 		59,315 +18.0% 26.70 US$1,787,461
2016-12-08 2016-12-07 B Purchase Grais Linda S

President and CEO

Executive Director
2,484 -29.2%
494.19
US$4,506,087 		2,484 -29.2% 494.19 US$4,506,087
2016-10-17 2016-10-13 B Purchase Bukofzer Stan

Chief Medical Officer

Officer
74,805 +17.7%
205.40
US$4,744,979 		74,805 +17.7% 205.40 US$4,744,979
2016-12-30 2016-09-12 S Sale POWELL MICHAEL Non-Executive Director
74 -0.8%
2.29
US$170 		74 -0.8% 2.29 US$170
2016-12-30 2016-09-12 S Sale POWELL MICHAEL Non-Executive Director
1,066 -0.8%
2.29
US$2,443 		1,066 -0.8% 2.29 US$2,443
2016-12-30 2016-09-12 S Sale POWELL MICHAEL Non-Executive Director
5,372 -0.8%
2.29
US$12,313 		5,372 -0.8% 2.29 US$12,313
2016-03-07 2016-03-04 B Purchase Grais Linda S

President and CEO

Executive Director
3,000 +5.0%
3.19
US$9,570 		3,000 +5.0% 3.19 US$9,570
2016-01-25 2016-01-22 B Purchase Grais Linda S

President and CEO

Executive Director
10,000 +20.0%
2.38
US$23,800 		10,000 +20.0% 2.38 US$23,800
2016-01-19 2016-01-15 B Purchase Grais Linda S

President and CEO

Executive Director
10,000 +25.0%
2.08
US$20,800 		10,000 +25.0% 2.08 US$20,800
2016-01-19 2016-01-15 B Purchase Aggarwal Gaurav

Chief Business Officer

Officer
10,000 +100.0%
2.15
US$21,500 		10,000 +100.0% 2.15 US$21,500
2016-01-19 2016-01-15 B Purchase Byrnes Michael

CFO and Treasurer

Officer
3,500 +53.8%
2.07
US$7,245 		3,500 +53.8% 2.07 US$7,245
2015-06-24 2015-06-23 B Purchase WIERENGA WENDALL Non-Executive Director
5,000 +inf%
3.71
US$18,550 		5,000 +inf% 3.71 US$18,550
2015-05-07 2015-05-07 B Purchase Patni Rajiv

Chief Development Officer

Officer
5,050 +inf%
3.97
US$20,048 		5,050 +inf% 3.97 US$20,048
2015-05-06 2015-05-06 B Purchase Aggarwal Gaurav

Chief Business Officer

Officer
7,500 +300.0%
3.62
US$27,150 		7,500 +300.0% 3.62 US$27,150
2015-05-06 2015-05-06 B Purchase Byrnes Michael

CFO and Treasurer

Officer
2,500 +62.5%
3.61
US$9,025 		2,500 +62.5% 3.61 US$9,025
2015-05-06 2015-05-06 B Purchase Grais Linda S

President and CEO

Executive Director
30,000 +300.0%
3.73
US$111,900 		30,000 +300.0% 3.73 US$111,900
2014-10-02 2014-10-01 B Purchase Byrnes Michael

VP, Finance & Treasurer

Officer
2,000 +100.0%
4.81
US$9,620 		2,000 +100.0% 4.81 US$9,620
2014-07-15 2014-07-11 B Purchase TETLOW SHARON

Acting CFO & Treasurer

Officer
3,000 +inf%
5.83
US$17,487 		3,000 +inf% 5.83 US$17,487
2014-07-15 2014-07-11 B Purchase Grais Linda S

President and CEO

Executive Director
10,000 +inf%
5.93
US$59,280 		10,000 +inf% 5.93 US$59,280
2013-07-17 2013-07-15 B Purchase Kjellson Nina S Non-Executive Director
431,435 +109.4%
6.03
US$2,600,000 		431,435 +109.4% 6.03 US$2,600,000
2013-07-17 2013-07-15 B Purchase SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
4,400 +45.9%
6.03
US$26,516 		4,400 +45.9% 6.03 US$26,516
2013-07-17 2013-07-15 B Purchase SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
63,957 +45.9%
6.03
US$385,430 		63,957 +45.9% 6.03 US$385,430
2013-07-17 2013-07-15 B Purchase POWELL MICHAEL Non-Executive Director
4,400 +45.9%
6.03
US$26,516 		4,400 +45.9% 6.03 US$26,516
2013-07-17 2013-07-15 B Purchase POWELL MICHAEL Non-Executive Director
63,957 +45.9%
6.03
US$385,430 		63,957 +45.9% 6.03 US$385,430
2013-07-17 2013-07-15 B Purchase POWELL MICHAEL Non-Executive Director
322,809 +45.9%
6.03
US$1,945,376 		322,809 +45.9% 6.03 US$1,945,376
2013-07-17 2013-07-15 B Purchase SOFINNOVA VENTURE PARTNERS VI L P Large shareholder
322,809 +45.9%
6.03
US$1,945,376 		322,809 +45.9% 6.03 US$1,945,376
2013-07-16 2013-07-15 B Purchase BLAIR JAMES C Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase BLAIR JAMES C Large shareholder
7,333 +inf%
6.03
US$44,192 		7,333 +inf% 6.03 US$44,192
2013-07-16 2013-07-15 B Purchase SCHOEMAKER KATHLEEN K Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase SCHOEMAKER KATHLEEN K Large shareholder
7,333 +inf%
6.03
US$44,192 		7,333 +inf% 6.03 US$44,192
2013-07-16 2013-07-15 B Purchase Halak Brian K Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase Halak Brian K Large shareholder
7,333 +inf%
6.03
US$44,192 		7,333 +inf% 6.03 US$44,192
2013-07-16 2013-07-15 B Purchase TREU JESSE I Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase TREU JESSE I Large shareholder
7,333 +inf%
6.03
US$44,192 		7,333 +inf% 6.03 US$44,192
2013-07-16 2013-07-15 B Purchase VITULLO NICOLE Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase VITULLO NICOLE Large shareholder
7,333 +inf%
6.03
US$44,192 		7,333 +inf% 6.03 US$44,192
2013-07-16 2013-07-15 B Purchase DOVEY BRIAN H Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase DOVEY BRIAN H Large shareholder
7,333 +inf%
6.03
US$44,192 		7,333 +inf% 6.03 US$44,192
2013-07-16 2013-07-15 B Purchase Domain Partners VI, L.P. Large shareholder
331,873 +21.2%
6.03
US$1,999,999 		331,873 +21.2% 6.03 US$1,999,999
2013-07-16 2013-07-15 B Purchase BLAIR JAMES C Large shareholder
988,285 +inf%
6.03
US$5,955,801 		988,285 +inf% 6.03 US$5,955,801
2013-07-16 2013-07-15 B Purchase SCHOEMAKER KATHLEEN K Large shareholder
988,285 +inf%
6.03
US$5,955,801 		988,285 +inf% 6.03 US$5,955,801
2013-07-16 2013-07-15 B Purchase Halak Brian K Large shareholder
988,285 +inf%
6.03
US$5,955,801 		988,285 +inf% 6.03 US$5,955,801
2013-07-16 2013-07-15 B Purchase TREU JESSE I Large shareholder
988,285 +inf%
6.03
US$5,955,801 		988,285 +inf% 6.03 US$5,955,801
2013-07-16 2013-07-15 B Purchase VITULLO NICOLE Large shareholder
988,285 +inf%
6.03
US$5,955,801 		988,285 +inf% 6.03 US$5,955,801
2013-07-16 2013-07-15 B Purchase DOVEY BRIAN H Large shareholder
988,285 +inf%
6.03
US$5,955,801 		988,285 +inf% 6.03 US$5,955,801
2012-03-14 2012-03-14 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
4,592 +2.0%
3.01
US$13,801 		4,592 +2.0% 3.01 US$13,801
2012-03-14 2012-03-14 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
7,484 +3.4%
2.99
US$22,370 		7,484 +3.4% 2.99 US$22,370
2012-03-14 2012-03-14 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
34,544 +1.0%
3.01
US$103,822 		34,544 +1.0% 3.01 US$103,822
2012-03-14 2012-03-14 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
56,294 +1.6%
2.99
US$168,268 		56,294 +1.6% 2.99 US$168,268
2012-03-14 2012-03-14 B Purchase 14159 capital (GP), LLC Large shareholder
910 +1.6%
3.01
US$2,735 		910 +1.6% 3.01 US$2,735
2012-03-14 2012-03-14 B Purchase 14159 capital (GP), LLC Large shareholder
1,482 +2.7%
2.99
US$4,430 		1,482 +2.7% 2.99 US$4,430
2012-03-14 2012-03-13 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
15,599 +7.6%
2.96
US$46,143 		15,599 +7.6% 2.96 US$46,143
2012-03-14 2012-03-13 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
159,015 +4.8%
2.96
US$470,382 		159,015 +4.8% 2.96 US$470,382
2012-03-14 2012-03-13 B Purchase 14159 capital (GP), LLC Large shareholder
4,186 +8.2%
2.96
US$12,383 		4,186 +8.2% 2.96 US$12,383
2012-03-14 2012-03-12 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
56,187 +37.9%
2.55
US$143,277 		56,187 +37.9% 2.55 US$143,277
2012-03-14 2012-03-12 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
32,155 +27.7%
2.34
US$75,230 		32,155 +27.7% 2.34 US$75,230
2012-03-14 2012-03-12 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
4,363 +3.9%
1.87
US$8,159 		4,363 +3.9% 1.87 US$8,159
2012-03-14 2012-03-12 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
572,737 +21.1%
2.55
US$1,460,479 		572,737 +21.1% 2.55 US$1,460,479
2012-03-14 2012-03-12 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
327,769 +13.7%
2.34
US$766,848 		327,769 +13.7% 2.34 US$766,848
2012-03-14 2012-03-12 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
44,467 +1.9%
1.87
US$83,153 		44,467 +1.9% 1.87 US$83,153
2012-03-14 2012-03-12 B Purchase 14159 capital (GP), LLC Large shareholder
15,076 +41.8%
2.55
US$38,444 		15,076 +41.8% 2.55 US$38,444
2012-03-14 2012-03-12 B Purchase 14159 capital (GP), LLC Large shareholder
8,628 +31.5%
2.34
US$20,186 		8,628 +31.5% 2.34 US$20,186
2012-03-14 2012-03-12 B Purchase 14159 capital (GP), LLC Large shareholder
1,170 +4.5%
1.87
US$2,188 		1,170 +4.5% 1.87 US$2,188
2012-03-14 2012-03-12 B Purchase Baker Biotech Capital (GP), LLC Large shareholder
1,601 +1.5%
1.89
US$3,019 		1,601 +1.5% 1.89 US$3,019
2012-03-14 2012-03-12 B Purchase Baker Brothers Life Sciences Capital (GP), LLC Large shareholder
16,326 +0.7%
1.89
US$30,788 		16,326 +0.7% 1.89 US$30,788
2012-03-14 2012-03-12 B Purchase 14159 capital (GP), LLC Large shareholder
430 +1.7%
1.89
US$811 		430 +1.7% 1.89 US$811
2011-10-04 2011-09-30 B Purchase Moore David

VP, Commercial Operations

Officer
1,050 +inf%
2.58
US$2,709 		1,050 +inf% 2.58 US$2,709
2011-04-06 2011-04-06 B Purchase BDC CAPITAL INC. Large shareholder
1,000,000 +80.7%
4.00
US$4,000,000 		1,000,000 +80.7% 4.00 US$4,000,000
2011-04-06 2011-04-06 B Purchase THOMAS MCNERNEY & PARTNERS LP Large shareholder
2,966 +0.1%
4.00
US$11,864 		2,966 +0.1% 4.00 US$11,864
2011-04-06 2011-04-06 B Purchase THOMAS MCNERNEY & PARTNERS LP Large shareholder
14,568 +0.5%
4.00
US$58,272 		14,568 +0.5% 4.00 US$58,272
2011-04-06 2011-04-06 B Purchase THOMAS MCNERNEY & PARTNERS LP Large shareholder
794,966 +36.3%
4.00
US$3,179,864 		794,966 +36.3% 4.00 US$3,179,864
2011-04-06 2011-04-06 B Purchase H.I.G. Ventures - Tranzyme, LLC Large shareholder
812,500 +37.1%
4.00
US$3,250,000 		812,500 +37.1% 4.00 US$3,250,000
2011-04-06 2011-04-06 B Purchase QUAKER BIO VENTURES LP Large shareholder
375,000 +17.1%
4.00
US$1,500,000 		375,000 +17.1% 4.00 US$1,500,000
Explore more

More insider trading research around Ocera Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America